MIVAC

The Knut and Alice Wallenberg Foundation is investing a little over SEK 16 million in the development of new, highly-efficient vaccines that can be administered as a drink or nasal spray. In cooperation with Chalmers University of Technology and Lund University, researchers at the Sahlgrenska Academy now hope to develop mucal inoculations based on targeted nanoparticles.